US 8354115
CD40 ligand adjuvant for respiratory syncytial virus
granted A61KA61K2039/53A61K2039/55516
Quick answer
US patent 8354115 (CD40 ligand adjuvant for respiratory syncytial virus) held by THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION
- Grant date
- Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/53, A61K2039/55516, A61K2039/57, A61K38/177